KEAP1, an intrinsic inhibitor of NRF2, plays a role in maintaining cellular redox homeostasis under low ROS levels [74, 160]
Major funding for NOVA is provided by the NOVA Science Trust and PBS viewers.
Why this matters in India Indias GLP-1 market has exploded: 113 crore (2022) 1,579 crore (2026) Current leaders: Tirzepatide (Mounjaro): ~988 crore Semaglutide brands: ~474 crore But access remains limited to patients comfortable with injections and premium pricing
For instance, treating the frown lines between the eyebrows may require anywhere from 20 to 30 units, while treating the crows feet around the eyes may require 12 to 20 units
Kelly, Kara M
These drugs are typically recommended for people who: Have a BMI of 30+ , OR Have a BMI of 27+ with a weight-related health condition , such as type 2 diabetes, high blood pressure, insulin resistance, or sleep apnea